Protocol for a randomized multicenter study for isolated skin vasculitis (ARAMIS) comparing the efficacy of three drugs: azathioprine, colchicine, and dapsone

Table 3 Protocol glucocorticoid dose-tapering regimens for patients given prednisone during the first 10 weeks (of each study stage) for a skin vasculitis flare

At week 12 (Stages 1 and 2), all patients must be off prednisone
For patients requiring a second course of prednisone for vasculitis flare, the study drug will be considered a treatment failure

ISSN: 1745-6215